2-Methylbenzylamine → [5-(5-Methoxy-2-trifluoromethyl-benzoimidazol-1-yl)-pyrazin-2-yl]-(2-methyl-benzyl)-amine

HRID 1642275Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1642275
Br[C:2]1[N:3]=[CH:4][C:5]([N:8]2[C:12]3[CH:13]=[CH:14][C:15]([O:17][CH3:18])=[CH:16][C:11]=3[N:10]=[C:9]2[C:19]([F:22])([F:21])[F:20])=[N:6][CH:7]=1.FC1C=CC=C(F)C=1C(NC1C=NC(N2C3C=CC(OC)=CC=3N=C2C(F)(F)F)=CN=1)=O.[CH3:55][C:56]1[CH:63]=[CH:62][CH:61]=[CH:60][C:57]=1[CH2:58][NH2:59].N1CCC[C@H]1C(O)=O>CS(C)=O.[Cu]I.CCOC(C)=O>[CH3:18][O:17][C:15]1[CH:14]=[CH:13][C:12]2[N:8]([C:5]3[N:6]=[CH:7][C:2]([NH:59][CH2:58][C:57]4[CH:60]=[CH:61][CH:62]=[CH:63][C:56]=4[CH3:55])=[N:3][CH:4]=3)[C:9]([C:19]([F:22])([F:21])[F:20])=[N:10][C:11]=2[CH:16]=1

Komponenten

8

Edukt 4

HCID 69932-MethylbenzylamineHCID 145742L-ProlineHCID 247517822,6-difluoro-N-[5-(5-methoxy-2-trifluoromethyl-benzoimidazol-1-yl)-pyrazin-2-yl]-benzamideHCID 573569041-(5-Bromopyrazin-2-YL)-2-(trifluoromethyl)-5-methoxy-1H-benzo[D]imidazole

Produkt 1

HCID 24752641[5-(5-Methoxy-2-trifluoromethyl-benzoimidazol-1-yl)-pyrazin-2-yl]-(2-methyl-benzyl)-amineAusbeute 46,5 %

Reagenzien, Katalysatoren, Lösungsmittel 3

HCID 24350Copper(1+) iodide; Copper(I) iodide; Cuprous iodide; Cuprous iodide (CuI)KatalysatorHCID 679Dimethyl SulfoxideLösungsmittelHCID 8857Ethyl AcetateLösungsmittel

Versuchsvorschrift

Into a 50 mL roundbottom flask, was placed a solution of 1-(5-bromo-pyrazin-2-yl)-5-methoxy-2-trifluoromethyl-1H-benzoimidazole (iv) (50 mg, 0.13 mmol) in DMSO (5 mL) (1-(5-bromo-pyrazin-2-yl)-5-methoxy-2-trifluoromethyl-1H-benzoimidazole (iv) was prepared as described for Compound 1 above). To this was added 2-methyl-benzylamine (40 mg, 0.33 mmol) followed by CuI (10 mg, 0.05 mmol). To the mixture was added L-proline (20 mg, 0.17 mmol). The resulting solution was held at 50° C. for 1 hr while the reaction progress was monitored by TLC (EtOAc/PE=1:2). After completion, the reaction mixture was allowed to cool to room temperature, then washed twice with H2O (30 mL each). After removal of the volatile components under vacuum, the residue was purified by eluting through a silica gel column with a 1:10 EtOAc/PE solvent system. This resulted in 25 mg (44%) of the product [5-(5-Methoxy-2-trifluoromethyl-benzoimidazol-1-yl)-pyrazin-2-yl]-(2-methyl-benzyl)-amine (Compound 46) as a white solid.

Aufarbeitung

  1. customInto a 50 mL roundbottom flask, was placed
  2. washwashed twice with H2O (30 mL each)
  3. customAfter removal of the volatile components under vacuum
  4. customthe residue was purified
  5. washby eluting through a silica gel column with a 1:10 EtOAc/PE solvent system

Quellen und Nachweise

ORD-Eintrag
ord-d3693f3834d94b04adacd9b5f0dcae34
Quelldatensatz
uspto-grants-2012_02
Patentnummer
US08119643B2

Notizen zur Reaktion

Wird geladen…